Annual Total Expenses
$243.01 M
+$46.29 M+23.53%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual total expenses is $243.01 million, with the most recent change of +$46.29 million (+23.53%) on December 31, 2023.
- During the last 3 years, STRO annual total expenses has risen by +$129.23 million (+113.58%).
- STRO annual total expenses is now at all-time high.
Performance
STRO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$76.44 M
+$2.05 M+2.75%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly total expenses is $76.44 million, with the most recent change of +$2.05 million (+2.75%) on September 30, 2024.
- Over the past year, STRO quarterly total expenses has increased by +$5.87 million (+8.32%).
- STRO quarterly total expenses is now at all-time high.
Performance
STRO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
STRO Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +23.5% | +8.3% |
3 y3 years | +113.6% | +8.3% |
5 y5 years | +221.3% | +8.3% |
STRO Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +51.5% | at high | +69.8% |
5 y | 5-year | at high | +147.4% | at high | +195.3% |
alltime | all time | at high | +316.4% | at high | +336.9% |
Sutro Biopharma Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $76.44 M(+2.8%) |
Jun 2024 | - | $74.39 M(+6.9%) |
Mar 2024 | - | $69.60 M(-1.4%) |
Dec 2023 | $243.01 M(+23.5%) | $70.57 M(+15.8%) |
Sep 2023 | - | $60.94 M(+7.7%) |
Jun 2023 | - | $56.59 M(+3.1%) |
Mar 2023 | - | $54.91 M(-5.1%) |
Dec 2022 | $196.72 M(+22.6%) | $57.85 M(+24.8%) |
Sep 2022 | - | $46.36 M(-2.4%) |
Jun 2022 | - | $47.48 M(+5.4%) |
Mar 2022 | - | $45.03 M(-1.4%) |
Dec 2021 | $160.40 M(+41.0%) | $45.69 M(+5.8%) |
Sep 2021 | - | $43.19 M(+14.1%) |
Jun 2021 | - | $37.85 M(+12.4%) |
Mar 2021 | - | $33.67 M(+1.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $113.78 M(+15.9%) | $33.12 M(+16.5%) |
Sep 2020 | - | $28.44 M(+9.9%) |
Jun 2020 | - | $25.89 M(-1.7%) |
Mar 2020 | - | $26.33 M(+0.9%) |
Dec 2019 | $98.20 M(+29.8%) | $26.09 M(+4.3%) |
Sep 2019 | - | $25.01 M(+3.3%) |
Jun 2019 | - | $24.21 M(+5.7%) |
Mar 2019 | - | $22.89 M(+2.4%) |
Dec 2018 | $75.64 M(+6.5%) | $22.36 M(+24.3%) |
Sep 2018 | - | $17.99 M(+1.1%) |
Jun 2018 | - | $17.79 M(+1.7%) |
Mar 2018 | - | $17.50 M(-8.9%) |
Dec 2017 | $71.01 M(+21.7%) | $19.21 M(+3.5%) |
Sep 2017 | - | $18.56 M |
Dec 2016 | $58.37 M | - |
FAQ
- What is Sutro Biopharma annual total expenses?
- What is the all time high annual total expenses for Sutro Biopharma?
- What is Sutro Biopharma annual total expenses year-on-year change?
- What is Sutro Biopharma quarterly total expenses?
- What is the all time high quarterly total expenses for Sutro Biopharma?
- What is Sutro Biopharma quarterly total expenses year-on-year change?
What is Sutro Biopharma annual total expenses?
The current annual total expenses of STRO is $243.01 M
What is the all time high annual total expenses for Sutro Biopharma?
Sutro Biopharma all-time high annual total expenses is $243.01 M
What is Sutro Biopharma annual total expenses year-on-year change?
Over the past year, STRO annual total expenses has changed by +$46.29 M (+23.53%)
What is Sutro Biopharma quarterly total expenses?
The current quarterly total expenses of STRO is $76.44 M
What is the all time high quarterly total expenses for Sutro Biopharma?
Sutro Biopharma all-time high quarterly total expenses is $76.44 M
What is Sutro Biopharma quarterly total expenses year-on-year change?
Over the past year, STRO quarterly total expenses has changed by +$5.87 M (+8.32%)